[Physical training and low-dose heparin-calcium in patients suffering from chronic obliterating arteriopathy of the lower limbs with intermittent claudication]
- PMID: 8767599
[Physical training and low-dose heparin-calcium in patients suffering from chronic obliterating arteriopathy of the lower limbs with intermittent claudication]
Abstract
In the treatment of peripheral obliterating arteriopathy (POA) physical training provides clear results in terms of increased walking autonomy; it is still not fully clear whether the positive effects of physical training can be further improved by concomitant back-up drug therapy. For this purpose 374 patients of both sexes, with a mean age of 64 years, suffering from chronic peripheral obliterating arteriopathy of the lower limbs were enrolled in a controlled open clinical trial, instructed to follow a programme of physical training and randomly allocated to low dose treatment with heparin calcium (12,500 IU/day) for 6 months. An improvement in the claudicometric parameters (free gait interval, absolute gait interval and recovery time) measured at constant speed and in the resting Winsor ankle/arm index of the most severely damaged limb were observed in both groups. These improvements were significantly greater in the group receiving pharmacological treatment (p < 0.01) and efficacy increased in line with basal deambulatory impairment. The results obtained and the good tolerance of the drug underline the clinical efficacy of heparin calcium at low doses in association with a physical training programme in patients suffering from Fontaine's stage II peripheral obliterating arteriopathy.
Similar articles
-
Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.Int J Clin Pharmacol Ther. 1994 Dec;32(12):646-51. Int J Clin Pharmacol Ther. 1994. PMID: 7881702 Clinical Trial.
-
Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.Int Angiol. 2008 Jun;27(3):253-9. Int Angiol. 2008. PMID: 18506129 Clinical Trial.
-
[Effect of calciparine in the mid-term treatment of peripheral arteriopathy of the lower extremities].Minerva Cardioangiol. 1993 Oct;41(10):465-8. Minerva Cardioangiol. 1993. PMID: 8302443 Clinical Trial. Italian.
-
[Methods and results of controlled walking training in patients with peripheral arterial occlusive disease].Z Arztl Fortbild Qualitatssich. 1999 Nov;93(9):626-32. Z Arztl Fortbild Qualitatssich. 1999. PMID: 10666825 Review. German.
-
Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality.Acta Med Scand Suppl. 1976;599:7-84. Acta Med Scand Suppl. 1976. PMID: 16981325 Review.
Cited by
-
Exercise for intermittent claudication.Cochrane Database Syst Rev. 2017 Dec 26;12(12):CD000990. doi: 10.1002/14651858.CD000990.pub4. Cochrane Database Syst Rev. 2017. PMID: 29278423 Free PMC article.
-
Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication.Cochrane Database Syst Rev. 2014 May 7;2014(5):CD001999. doi: 10.1002/14651858.CD001999.pub2. Cochrane Database Syst Rev. 2014. PMID: 24801382 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical